cervical carcinoma
Showing 1 - 25 of 51
Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +18 more
- Clinical Encounter
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jul 24, 2023
Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)
Not yet recruiting
- Cervical Cancer
- Cervical Carcinoma
-
Guangzhou, ChinaSun Yat-sen University Cancer Cetntre
Apr 9, 2023
Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)
Recruiting
- Clear Cell Renal Cell Carcinoma
- +4 more
- CTX131
-
Nashville, TennesseeResearch Site 1
Mar 21, 2023
Blood, Bone Marrow, Tumor, or Tissue Samples From Cancer to
Recruiting
- Renal Cell Carcinoma
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Cervical Carcinoma, Endometrial Carcinoma, Endometriosis Trial in Scottsdale, Jacksonville, Rochester (Quality-of-Life
Recruiting
- Cervical Carcinoma
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Cervical Carcinoma Trial in Philadelphia (Health Promotion and Education, Survey Administration, Interview)
Completed
- Cervical Carcinoma
- Health Promotion and Education
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Dec 13, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)
Recruiting
- Cervical Carcinoma
- TC-E202 cells
- +3 more
-
Chongqing, Chongqing, ChinaXiaochun Cheng
Oct 20, 2022
Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma Trial in France, Italy, Spain (Standard treatment: Control arm,
Not yet recruiting
- Cervical Carcinoma
- +2 more
- Standard treatment: Control arm
- Experimental arm
-
Bordeaux, France
- +18 more
Oct 12, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Cervical Carcinoma Trial in Worldwide (LN-145, LN-145 + pembrolizumab)
Recruiting
- Cervical Carcinoma
- LN-145
- LN-145 + pembrolizumab
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis
Enrolling by invitation
- Cervical Carcinoma
- Human Papillomavirus Infection
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
- +3 more
-
Liberia, Guanacaste, Costa RicaAgencia Costarricense de Investigaciones Biomédicas - Fundación
Aug 11, 2022
Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)
Recruiting
- Microsatellite High Cancers
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 8, 2022
Melanoma, Non Small Cell Lung Cancer, Cervical Carcinoma Trial in Tianjin (Autologous tumor infiltrating lymphocytes (TILs))
Recruiting
- Melanoma
- +2 more
- Autologous tumor infiltrating lymphocytes (TILs)
-
Tianjin, ChinaTianjin Beichen Hospital
Aug 1, 2022
Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma Trial in Seattle (Training, Cancer Screening intervention, Survey
Completed
- Breast Carcinoma
- +3 more
- Training
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 22, 2022
Individuals Who Have Experienced Sexual Trauma
Not yet recruiting
- Cervical Carcinoma
- Human Papillomavirus Infection
- HPV Self-Collection
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Cervical Carcinoma, Malignant Female Reproductive System Tumor, Vaginal Carcinoma Trial in Philadelphia (Perflubutane
Recruiting
- Cervical Carcinoma
- +3 more
- Perflubutane Microbubble
- Contrast-Enhanced Ultrasound
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jul 5, 2022
Cervical Cancer Through Self-Administered Screening
Recruiting
- Cervical Carcinoma
- Human Papillomavirus-Related Carcinoma
- HPV testing
- Questionnaire Administration
-
Kampala, UgandaMakerere University College of Health Sciences School of Medicin
Apr 25, 2022
Breast Carcinoma, Cancer Survivor, Cervical Carcinoma Trial in Columbus (Laser Therapy, Questionnaire Administration)
Active, not recruiting
- Breast Carcinoma
- +4 more
- Laser Therapy
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 20, 2022
Cervical Carcinoma, Human Papillomavirus-Related Malignant Tumor Trial in Lexington, Columbus, Charlottesville (Best Practice,
Recruiting
- Cervical Carcinoma
- Human Papillomavirus-Related Malignant Neoplasm
- Best Practice
- +3 more
-
Lexington, Kentucky
- +2 more
Apr 18, 2022
Cervical Carcinoma, Chemoradiotherapy, Anti-programmed Cell Death Receptor 1 Trial in Beijing (Camrelizumab plus Concurrent
Recruiting
- Cervical Carcinoma
- +8 more
- Camrelizumab plus Concurrent chemoradiotherapy
-
Beijing, Beijing, ChinaLei Li
Apr 5, 2022
Cervical Carcinoma Trial in Zhuhai (Indocyanine green)
Recruiting
- Cervical Carcinoma
- Indocyanine green
-
Zhuhai, Guangdong, ChinaFifthSunYetSen
Mar 17, 2022
Cervical Carcinoma, Endometrial Carcinoma Trial in Salt Lake City (Hypofractionated Radiation Therapy)
Recruiting
- Cervical Carcinoma
- Endometrial Carcinoma
- Hypofractionated Radiation Therapy
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Mar 1, 2022
Breast Carcinoma, Cervical Carcinoma, Ovarian Carcinoma Trial in United States (Bupropion 150 mg XL, Placebo)
Completed
- Breast Carcinoma
- +6 more
- Bupropion 150 mg XL
- Placebo
-
Anaheim, California
- +361 more
Feb 10, 2022